145 related articles for article (PubMed ID: 32827514)
1. Identification and activity of monoamine oxidase in the orb-weaving spider Larinioides cornutus.
Wilson RJ; Ahmed TH; Rahman MM; Cartwright BM; Jones TC
Gen Comp Endocrinol; 2020 Dec; 299():113580. PubMed ID: 32827514
[TBL] [Abstract][Full Text] [Related]
2. Octopamine and serotonin have opposite effects on antipredator behavior in the orb-weaving spider, Larinioides cornutus.
Jones TC; Akoury TS; Hauser CK; Neblett MF; Linville BJ; Edge AA; Weber NO
J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2011 Aug; 197(8):819-25. PubMed ID: 21484264
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology.
Mialet-Perez J; Santin Y; Parini A
J Neural Transm (Vienna); 2018 Nov; 125(11):1627-1634. PubMed ID: 30043181
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.
Garrick NA; Murphy DL
Biochem Pharmacol; 1982 Dec; 31(24):4061-6. PubMed ID: 7159481
[TBL] [Abstract][Full Text] [Related]
5. MAO-A and -B gene knock-out mice exhibit distinctly different behavior.
Shih JC; Chen K
Neurobiology (Bp); 1999; 7(2):235-46. PubMed ID: 10591056
[TBL] [Abstract][Full Text] [Related]
6. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
7. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.
Bortolato M; Godar SC; Tambaro S; Li FG; Devoto P; Coba MP; Chen K; Shih JC
Neuropharmacology; 2013 Dec; 75():223-32. PubMed ID: 23871843
[TBL] [Abstract][Full Text] [Related]
8. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
[TBL] [Abstract][Full Text] [Related]
9. Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
Steuer AE; Boxler MI; Stock L; Kraemer T
Toxicol Lett; 2016 Jan; 243():48-55. PubMed ID: 26721607
[TBL] [Abstract][Full Text] [Related]
10. Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A.
Pizzinat N; Girolami JP; Parini A; Pecher C; Ordener C
Kidney Int; 1999 Oct; 56(4):1391-9. PubMed ID: 10504491
[TBL] [Abstract][Full Text] [Related]
11. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
O'Carroll AM; Fowler CJ; Phillips JP; Tobbia I; Tipton KF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):198-202. PubMed ID: 6408492
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
Hurst JH; Kulakowski EC
Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
[TBL] [Abstract][Full Text] [Related]
13. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
Nandigama RK; Miller JR; Edmondson DE
Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
[TBL] [Abstract][Full Text] [Related]
14. [Properties of intestinal monoamine oxidase in the rat].
Verevkina IV; Asnina VV; Gorkin VZ
Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
16. Brain monoamine oxidase A activity predicts trait aggression.
Alia-Klein N; Goldstein RZ; Kriplani A; Logan J; Tomasi D; Williams B; Telang F; Shumay E; Biegon A; Craig IW; Henn F; Wang GJ; Volkow ND; Fowler JS
J Neurosci; 2008 May; 28(19):5099-104. PubMed ID: 18463263
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the inhibition of monoamine oxidase A by bioactive coffee compounds protecting serotonin degradation.
Grzelczyk J; Budryn G; Peña-García J; Szwajgier D; Gałązka-Czarnecka I; Oracz J; Pérez-Sánchez H
Food Chem; 2021 Jun; 348():129108. PubMed ID: 33540300
[TBL] [Abstract][Full Text] [Related]
18. [Kinetic properties of monoamine oxidase isoenzymes from the bovine brain].
Moskvitina TA; Kuchina NE; Gorkin VZ
Vopr Med Khim; 1982; 28(5):127-31. PubMed ID: 7179829
[TBL] [Abstract][Full Text] [Related]
19. [Studies on monoamine oxidase. (Report 37) Effects of oxygen concentration on rat liver and brain monoamine oxidase (author's transl)].
Nakagawa K
Nihon Yakurigaku Zasshi; 1977 Apr; 73(3):297-305. PubMed ID: 21126
[TBL] [Abstract][Full Text] [Related]
20. [Brain monoamine oxidase in schizophrenia].
Moskvitina TA; Kamyshanskaia NS; Smirnov AV; Prilipko LL; Gorkin VZ
Biull Eksp Biol Med; 1985 Jun; 99(6):671-2. PubMed ID: 4016256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
